Metabolic Research's Stemulite Fitness Formula in top twenty products on GNC shelves for 2009

NewsGuard 100/100 Score

Metabolic Research, Inc. (OTC:MTBR) has been informed that its Stemulite™ Fitness Formula was in the top twenty products in revenue on General Nutrition Center (GNC) shelves for 2009.

“We appreciate the alliance with GNC and we are proud of their contributions to the growing awareness of the Stemulite™ brand “Fitness Formulas”

GNC has been the exclusive national “brick and mortar” retailer of Stemulite™ Fitness Formula for Men and Stemulite™ Fitness Formula for Women since February of 2009.

GNC, headquartered in Pittsburgh, Pa., is the leading global specialty retailer of nutritional products including vitamin, mineral, herbal and other specialty supplements and sports nutrition, diet and energy products. As of September 30, 2009, GNC has more than 3,500 retail locations in the United States.

Metabolic Research, Inc. President and Chief Executive Officer Robert Bakker stated, “We appreciate the alliance with GNC and we are proud of their contributions to the growing awareness of the Stemulite™ brand “Fitness Formulas” in the marketplace.”

Metabolic Research, Inc. markets its Stemulite™ brand of nutritional supplements as a multiple benefit nutritional foundation for everyday fitness.

http://www.metabolicresearchinc.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer